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Abstract: Steroid sex hormones have a significant effect on different organ systems. As far as gingiva are concerned, they 
can influence the cellular proliferation, differentiation and growth of keratinocytes and fibroblasts. Estrogen is mainly re-
sponsible for alterations in blood vessels and progesterone stimulates the production of inflammatory mediators. In addi-
tion, some micro-organisms found in the human mouth synthesize enzymes needed for steroid synthesis and catabolism. 
In women, during puberty, ovulation and pregnancy, there is an increase in the production of sex steroid hormones which 
results in increased gingival inflammation, characterized by gingival enlargement, increased gingival bleeding and crevi-
cular fluid flow and microbial changes. 
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INTRODUCTION  
  The main sex hormones exerting influence on the perio-
dontium are estrogen and progesterone. Estrogen and proges-
terone can significantly influence different organ systems [1, 
2]. For example, estrogens can influence the cytodifferentia-
tion of statified squamous epithelium, and the synthesis and 
maintenance of fibrous collagen [3]. Additionally, estrogen 
receptors in osteoblast-like cells provide a mechanism for 
direct action on bone while estrogen receptors in periosteal 
fibroblasts and periodontal ligament fibroblasts provide a 
mechanism for direct action on different periodontal tissues 
[1]. Estrogen, progesterone and chorionic gonadotropin, dur-
ing pregnancy, affect the microcircularity system by produc-
ing the following changes: swelling of endothelial cells and 
periocytes of the venules, adherence of granulocytes and 
platelets to vessel walls, formation of microthrombi, disrup-
tion of the perivascular mast cells, increased vascular perme-
ability and vascular proliferation [4-7]. Consequently, sys-
temic endocrine imbalances may have an important impact 
on periodontal pathogenesis, and, vise versa, changes in 
periodontal conditions might be associated with variations in 
sex hormone levels. This association is evident in the recent 
periodontal disease classification which includes the follow-
ing hormone related disease categories: puberty-associated 
gingivitis, menstrual cycle-associated gingivitis and preg-
nancy-associated gingivitis [1, 8]. 
MECHANISMS OF ACTION OF SEX STEROID 
HORMONES ON GINGIVA OF WOMEN 
  Sex steroid hormones have been shown to directly and 
indirectly exert influence on cellular proliferation, differen-
tiation and growth in target tissues, including keratinocytes  
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and fibroblasts in the gingiva [2, 9]. There are two theories 
for the actions of the hormones on these cells: a) change of 
the effectiveness of the epithelial barrier to bacterial insult 
and b) effect on collagen maintenance and repair.  
   Estradiol can induce cellular proliferation while depress-
ing protein production in cultures of human pre-menopausal 
gingival fibroblasts. This cellular proliferation appears to be 
the result of a specific population of cells within the parent 
culture that responds to physiologic concentrations of estra-
diol [10]. 
  In contrast to the stimulatory effects of estrogen on gin-
gival fibroblast proliferation, both collagen and non-collagen 
protein production were reduced when physiological concen-
trations of estradiol were introduced to fibroblasts in culture. 
The reductions of collagen and non-collagen protein produc-
tion by fibroblast strains were similar (approximately 30% 
reduction in comparison to controls); therefore, there was no 
effect of estrogen on the relative amount of collagen synthe-
sized by gingival fibroblasts. Similar effects of estrogen on 
protein synthesis have also been reported in other tissues. In 
human periodontal ligament cells, estrogen triggered an in 
vitro reduction in fibroblast collagen synthesis [11]. Fur-
thermore, fibroblasts derived from human anterior cruciate 
ligament have also exhibited a reduction of collagen synthe-
sis by more than 40% of controls at physiological concentra-
tions of estrogen [12]. More specifically, estrogen induced a 
dose dependent decrease in the production of pro-collagen I 
from anterior cruciate ligament fibroblasts [13] of young 
adult women. 
  Sex steroid hormones have also been shown to increase 
the rate of folate metabolism in oral mucosa [14]. Since fo-
late is required for tissue maintenance, increased metabolism 
can deplete folate stores and inhibit tissue repair [9]. 
  Estrogen is the main sex steroid hormone responsible for 
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stimulating endometrial blood flow during the estrogen 
plasma rise seen in the follicular phase. Subsequently, en-
dometrial blood flow decreased during the luteal phase of the 
cycle with waning estrogen levels [15]. In contrast, proges-
terone has been shown to have little effect on the vasculature 
of systemic target tissues [9]. On the other hand, in gingiva 
and other non-periodontal intraoral tissues, more evidence 
has accumulated for progesterone affecting the local vascula-
ture than for estrogen. In addition, progesterone has been 
shown to reduce corpuscular flow rate, allowing for accumu-
lation of inflammatory cells, increased vascular permeability 
and proliferation [16-19]. Human PDL cells possessed im-
munoreactivity for (towards) estrogen receptors. More spe-
cifically estrogenic effects in PDL cells are mediated via 
estrogen receptors beta (ERbeta), whereas no immunoreac-
tivity was expressed in these cells for progesterone receptors, 
which implies that progesterone does not have a direct effect 
on PDL cell function [20].  
  These hormones may alter immunologic factors and re-
sponses, including antigen expression and presentation, and 
cytokine production, as well as the expression of apoptotic 
factors and cell death [21]. Several studies have focused on 
the observation that immune system components have been 
identified as possessing sex steroid receptors [9]. In mice, 
the presence of oestrogen receptors on various immune cells 
has been demonstrated, as well as the presence of androgen 
receptors on T and B lymphocytes [22]. Progesterone in par-
ticular has been shown to stimulate the production of the 
inflammatory mediator, prostaglandin E2 and to enhance the 
accumulation of polymorphonuclear leukocytes in the gingi-
val sulkus [23]. Progesterone has also been found to enhance 
the chemotaxis of polymorphonuclear leukocytes, while low 
concentrations of estradiol have been demonstrated to reduce 
polymorphonuclear leukocytes chemotaxis [24]. In addition, 
sex steroid hormones seem to modulate the production of 
cytokines [25], and progesterone has been shown to down-
regulate Il-6 production by human gingival fibroblasts to 
50% of that of control values [26, 27]. 
  According to a radically new insight into the
 diversity of 
human oral microflora, the human mouth consists of an es-
timated
 number of 19,000 phylotypes, which is considerably 
higher than previously
 reported [28]. Although the hypothe-
sis that hormonal changes in the menstrual cycle cause 
changes in the oral microbiota could not be confirmed [29]. 
Some micro-organisms, as Aggregatibacter. actinomycetem-
comitans, Porphyromonas gingivalis and Prevotella interme-
dia, are known to synthesize steroid metabolizing enzymes 
needed for steroid synthesis and catabolism [30]. The steroid 
metabolites may also contribute to nutritional requirements 
of the pathogens, or enable synthesis of matrices associated 
with host evasion mechanisms [31]. The need for an andro-
gen metabolic pathway in pathogens may be an adaptation to 
a parasitic presence in the host. Culture supernatants of these 
micro-organisms have been shown to enhance the expression 
of 5a-reductase activity in human gingiva and in cultured 
gingival fibroblasts, resulting in the formation of 5a-
dihydrotestosterone (DHT) from androgen substrate [32]. 
The DHT can influence protein synthetic activity in these 
pathogens, for which there is a variety of applications. Some 
of these functions are: a) the formation of surface capsular 
protein contributing to their evasion of host elimination 
mechanisms, such as phagocytosis, by preventing opsonisa-
tion b) persistence and dissemination with the host and c) 
interspecies aggregation and energy generation as a result of 
the electron transfers involved in these enzyme activities 
[31]. 5a-reductase activity can be activated in a phosphol-
ipidic environment [33]. Increased amounts of phospholi-
pases A2 and C are synthesized by periodontal pathogens 
(e.g. spirochaetes) during inflammatory episodes in the pe-
riodontium. Phospholipase C is also released from leuko-
cytes during cell lysis and in addition to degrading gingival 
crevicular epithelium it is also known to stimulate 5a-
reductase activity [32]. 
INFLUENCE ON PERIODONTIUM DURING PU-
BERTY 
  Puberty is a complex process of sexual maturation and it 
is responsible for changes in physical appearance and behav-
ior that are related to increased levels of the steroid sex hor-
mones, testosterone in males and estradiol in females [34].  
  Puberty gingivitis is characterized clinically by the onset 
of exuberant inflammation of the marginal and, by direct 
extension, adjacent attached gingiva, especially in the inter-
dental papillae [35, 36], with increased gingival bleeding 
during puberty [35]. This gingival enlargement, is found 
primarily on the facial surfaces, with the lingual surfaces 
remaining relatively unaltered [9]. 
  Several reports [37-39] have indicated that there is a sig-
nificant increase in gingivitis in children entering puberty 
and during the pubertal period. A peak prevalence of gingivi-
tis has been determined at 12 years, 10 months in females 
and 13 years, 7 months in males, which is consistent with the 
onset of puberty [40]. This increase is believed to be related, 
at least in part, to an alteration in the subgingival microflora. 
[41, 42] including the presence of Prevotella intermedia, 
which can substitute estrogen and progesterone for vitamin 
K, an essential bacterial growth factor [43, 44]. There also is 
an increase in the quantity of plaque in general [41] and 
other species in particular, including spirochetes, Capnocy-
tophagia sp., Actinomycetes sp., and Eikenella corrodens 
[38, 42, 45]. Capnocytophaga species have been associated 
with a tendency towards increased bleeding [45] Tiainen   
et al. [41] showed that the severity of puberty gingivitis was 
related more closely to plaque build up than to hormones. 
  The removal of local factors by oral hygiene techniques 
was the key to management of hormone-related gingivitis, as 
it was pointed by Oh et al. [46]. However, other studies have 
not confirmed these relationships [47, 48]. In a longitudinal 
study, Yanover and Ellen [48] were unable to detect any 
changes in the oral microbiota during puberty and found no 
correlation between plasma estradiol levels and levels of 
black pigmented anaerobic bacteria. 
INFLUENCE ON PERIODONTIUM DURING THE 
MENSTRUAL CYCLE 
  The menstrual cycle is a 25-30-day period, controlled by 
the secretion of sex hormones, which is responsible for con-
tinued ovulation until menopause [1, 32]. It can be divided 
into two phases: a proliferative and a secretory phase, corre-
sponding to pre- and post-ovulatory events in the ovaries. 
The proliferative phase is characterized by a gradual increase 
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a lesser degree, progesterone. At ovulation there is a sudden 
and marked increase in production of gonadotropin and of 
estrogens [50]. Lindhe and Attström [50] have demonstrated 
that a small gradual increase of the gingival exudation is 
observed in all females on the day of ovulation, while the 
secretory phase is characterized by a gradual decrease in 
gingival exudation. In a longitudinal study, Hugoson [51] 
discovered that gingival exudate increased by at least 20% 
during ovulation in more than 75% of the females examined. 
Lindhe and Attström [50] noted that during their menstrual 
cycles, women without clinical gingivitis showed no increase 
in gingival fluid, whereas those with gingivitis showed in-
creases in gingival fluid. It is generally accepted that in-
creased sex hormones during the menstrual cycle modulate 
the development of localized gingival inflammation, al-
though this has not been fully experimentally proven [26, 49, 
52-54]. More specifically, Holm-Pedersen and Loe in 1967 
[55] showed that no correlation existed between the condi-
tion of the gingiva and the different phases of the menstrual 
cycle in clinically healthy gingiva, whereas a significant de-
terioration of pre-existing gingivitis was observed during the 
day of menstruation. In contrast, Klein (1934) reported a 
“gingivitis menstrualis” and Muhlemann (1948) presented a 
“gingivitis intermenstrualis”. Lindhe and Attstrom (1967) 
studied the variations in gingival fluid flow during the men-
strual cycle and found a positive correlation between GCF 
and FSH and estrogens and a negative correlation between 
GCF and progesterone. More recently, Machtei et al. (2004) 
[52] in a longitudinal study of 18 premenopausal women 
reported no statistically significant differences in plaque in-
dex, but an increase in gingival index during ovulation and 
premenstruation. The cellular pathway for this hormonal-
tissue interaction has been studied only in the peripheral 
blood. Brannstrom et al. (1999) [53] reported that TNF-a 
showed significant fluctuation during the whole cycle, with 
surges just before OV and PM and implicated TNF-a as a 
mediator through which gingival inflammation is mediated. 
Gornstein et al. (1999) [54] and Lap et al. (1995) [26] found 
that Il-6 production is decreased by progesterone. They con-
cluded that this lends support to the hypothesis that increased 
sex hormones modulate the development of localized gingi-
val inflammation. Miyagi and coworkers [56] demonstrated 
that both estradiol (at 20ng/ml) and progesterone (in various 
concentrations) resulted in an elevated PGE2 production. 
INFLUENCE ON PERIODONTIUM DURING PREG-
NANCY 
  Pregnancy is accompanied by remarkable endocrine al-
terations. During this period, both progesterone and estrogen 
are elevated due to continuous production of these hormones 
by the corpus luteum. By the end of the third trimester, pro-
gesterone and estrogen reach peak plasma levels of 100 and 
6ng/ml respectively, which represent 10 and 30 times the 
levels observed during the menstrual cycle [2]. 
  The levels of sex steroid hormones in saliva also increase 
during pregnancy [57]. Pregnant women present more in-
flammation and gingival bleeding than the general popula-
tion and this effect is related to the dental biofilm, the micro-
bial flora and the hormonal levels [58]. Susceptibility to in-
fections (e.g. periodontal infection) increases during early 
gestation due to alterations in the immune system [59] and 
can be explained by the hormonal changes observed during 
pregnancy [60], suppression of T-cell activity [61], de-
creased neutrophil chemotaxis and phagocytosis, altered 
lymphocyte response and depressed antibody production 
[62] and even chronic maternal stress [63]. Pregnancy gingi-
vitis is extremely common and affects 30-100% of all preg-
nant women [9]. 
  Pregnancy gingivitis and is clinically characterized by an 
increase in probing depth and bleeding on probing [64] in-
creased gingival crevicular fluid flow [51] and microbial 
changes [9]. An in vitro study [65] showed that progesterone 
may control and reduce local production of matrix metallo-
proteinases, and thereby explain why pregnancy gingivitis is 
not necessarily characterized by progression to periodontitis. 
Rateitschak [66] reported a significant change in mobility 
during and after pregnancy, mainly because of an increase in 
the initial free intrasocket movement of the roots. Initial mo-
bility is dependent on the degree of vascularisation and the 
vascular volume of the periodontal membrane. When acting 
at high concentrations over longer periods of time, female 
sex hormones may have a hyperemic- and permeability-
increasing action on the periodontal vascular system. In re-
spect to the periodontal membrane, slight edema has a tooth 
extruding effect, with this mechanism leading to increased 
horizontal mobility [66]. 
  Other investigators [67] showed that experimentally de-
veloped gingivitis during pregnancy resulted in only limited 
microbial changes. Contradictory results have also been re-
ported in that hormonal changes during pregnancy may re-
sult in >55 times higher levels of bacteroides species in 
periodontal samples compared to non-pregnant women [68]. 
In addition to the gingival changes seen during pregnancy, 
0.5-9.6% of pregnant women also experience localized gin-
gival enlargement consistent with pyogenic granulomas. The 
pregnancy-associated pyogenic granuloma, or pregnancy 
tumor, is not a neoplasm at all, and clinically and histologi-
cally cannot be distinguished from pyogenic granulomas 
occurring in women who are not pregnant [9]. These lesions 
have been described as a painless, exophytic mass that has 
either a sessile or pedunculated base extending from the gin-
gival margin or, in most instances, from the interproximal 
tissues in the maxillary anterior [69]. The pregnancy tumor 
develops as a result of an exaggerated inflammatory re-
sponse to an irritation (often calculus), enlarges rapidly, 
bleeds easily and may range in color from purplish red to 
deep blue, although most commonly is red in color with 
small fibrin spots [3, 9, 70]. It rarely reaches more than 2cm 
in size and has a tendency to recur if not completely removed 
after pregnancy [70]. Kornman and Loesche [71] reported 
that during the second trimester, although plaque levels re-
mained constant, the ratio of subgingival bacterial anaer-
obes-to-aerobes increased, as well as proportions of Bacter-
oides melaninogenicus and P.intermedia. Subgingival plaque 
samples from these patients also demonstrated a significantly 
higher accumulation of estradiol and progesterone than 
plaque samples from the same patients at other time periods. 
As mentioned before, both estradiol and progesterone were 
shown to be selectively accumulated by P.i. as a substitute 
for vitamin K [44] and thus postulated to be acting as a 
growth factor for this micro-organism [72]. Jensen and co-
workers [72] demonstrated a 55-fold increase over the con-
trol group in the population of Bacteroides species in preg-
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INFLUENCE OF ORAL CONTRACEPTIVES ON PE-
RIODONTIUM 
  Oral contraceptives act to establish hormonal levels of 
pregnancy and they have similar clinical incidence on tis-
sues. Contrary to the 9-month duration of pregnancy, the 
effects of oral contraceptives may last much longer [70]. 
Lindhe and Björn, in a clinical study in 1967 [73], demon-
strated that regular use of contraceptive pills for 12 months 
increases the amount of exudates obtainable from the gingi-
val pockets of the anterior regions. Two years later, Kauf-
man and Gan [74] showed that a patient who received a 
weakly progestonic and strongly estrogenic contraceptive 
(1mg ethynodiol diacelate + 0.1 mg mestranol) presented 
with hyperplastic gingivitis and a pregnancy-tumor. Jensen 
and co-workers in 1981 [72] demonstrated a 16-fold increase 
over the control group in the population of Bacteroides spe-
cies in women taking contraceptives, whereas Klinger and 
co-workers in 1998 [75], reported that P.gingivalis and A.a. 
were not detected and there was a 4.8% increase in 
P.intermedia in women receiving a contraceptive containing 
0.02mg ethinyl estradiol and 0.15mg desogestrel after a 20-
day use of this contraceptive. Current oral contraceptives 
consist of low doses of estrogens (50mg/d) and 1.5mg/d of 
progestins, in contrast to early formulations which contained 
higher concentrations of sex steroid hormones. As a result of 
the new combination in oral contraceptives, if low plaque 
levels are established and maintained during the period of 
hormonal contraceptive usage, their effects on the periodon-
tium can be minimized [32]. 
MENOPAUSE 
  The menopause and the lack of ovarian steroids are 
known to promote important changes in connective tissue. 
[76] The mechanisms involved in this influence are not 
completely understood, but it is thought to be related to the 
action of estradiol on the connective tissue [77]. The meno-
pause triggers a wide range of changes in women’s bodies, 
and the oral cavity is also affected. Although elevated levels 
of ovarian hormones, as seen in pregnancy and oral contra-
ceptive usage, can lead to an increase of gingival inflamma-
tion with an accompanying increase in gingival exudates, 
[78] conversely, the menopause – the absence of ovarian sex 
steroids – has been related to a worsening in gingival health, 
and hormonal replacement therapy seems to ameliorate this 
trend [79]. An increase in gingivitis, periodontal disease, 
tooth loss and dry mouth has been reported [80] and hor-
mone replacement seems to be associated with decreased 
levels of several indicators of the severity of oral disease as 
compared with estrogen-insufficient women [81, 82]. 
  During the menopause estrogen deficiency is one of the 
most frequent causes of osteoporosis in women and a possi-
ble cause of bone loss and insufficient skeletal development 
in men. Estrogen plays an important role in the growth and 
maturation of bone as well as in the regulation of bone turn-
over in adult bone. During bone growth estrogen is needed 
for proper closure of epiphyseal growth plates both in fe-
males and in males. Also in the young skeleton estrogen de-
ficiency leads to increased osteoclast formation and en-
hanced bone resorption. In menopause estrogen deficiency 
induces cancellous as well as cortical bone loss. Highly in-
creased bone resorption in cancellous bone leads to general 
bone loss and destruction of local architecture because of 
penetrative resorption and microfractures. In cortical bone 
the first response of estrogen withdrawal is enhanced en-
docortical resorption. Later, also intracortical porosity in-
creases. These lead to decreased bone mass, disturbed archi-
tecture and reduced bone strength [83]. 
  The mechanism by which estrogen deficiency causes 
bone loss remains largely unknown. Estrogen deficiency 
leads to an increase in the immune function, which culmi-
nates in an increased production of TNF by activated T cells. 
TNF increases osteoclast formation and bone resorption both 
directly and by augmenting the sensitivity of maturing osteo-
clasts to the essential osteoclastogenic factor RANKL. In-
creased T cell production of TNF is induced by estrogen 
deficiency via a complex mechanism mediated by antigen-
presenting cells and involving the cytokines IFN-g, IL-7, and 
TGF-b. Experimental evidence suggests that estrogen pre-
vents bone loss by regulating T cell function and immune 
cell bone interactions. 
  Remarkable progress has been made in elucidating the 
cross-talk between the immune system and bone, and in un-
covering the mechanism by which sex steroids, infection, 
and inflammation lead to bone loss by disrupting the regula-
tion of the T lymphocyte function in animal models. If the 
findings in experimental animals are confirmed in humans, it 
will, perhaps, be appropriate to classify osteoporosis as an 
inflammatory, or even an auto-immune condition and cer-
tainly new therapeutic “immune” targets will emerge [84]. 
CONCLUSION 
  Female sex hormones are neither necessary nor sufficient 
to produce gingival changes by themselves. However, they 
may alter periodontal tissue responses to microbial plaque 
and thus indirectly contribute to periodontal disease. 
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